Summary
The reactions of a panel of 34 mouse monoclonal antibodies (MAbs) specific for the dengue-2 virus nonstructural-1 glycoprotein (NS1), were analysed using 174 overlapping synthetic nonameric peptides covering the entire sequence. Using this methodology, four epitopes were identified. One pair of MAbs, which defined a dengue-2/4 virus subcomplex epitope (24C: amino acids 299–309) using native NS1 proteins, showed the same reaction pattern with synthetic peptides containing the corresponding NS1 sequences of each virus serotype. One amino acid substitution, present in the sequences from the dengue-1/3 virus subcomplex abrogated almost all reaction by these MAbs. A dengue complex epitope (LX1: amino acids 111–121) was also located and peptides containing the sequences of each serotype were shown to contain only antigenically silent amino-acid substitutions. In contrast, MAbs which defined a dengue type-specific epitope (LD2: amino acids 25–33) and another dengue subcomplex epitope (24A: amino acids 61–69) failed to show the same reaction profiles using peptides of each serotype, suggesting that these determinants were partially dependent upon conformation. The LX1 epitope is a good candidate for further trials aimed at generating cross-protective immune responses to these viruses without the risk of antibody-dependent enhancement.
Similar content being viewed by others
References
Brandt WE (1988) Current status of dengue vaccines and prospect for the future. J Infect Dis 157: 1105–1111
Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S (1991) Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 44: 481–493
Eisenburg D (1984) Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 53: 595–623
Falconar AKI, Young PR (1990) Amino-acid sequence of protective epitopes on the dengue virus nonstructural glycoprotein, NS1. Workshop W8-007 VIII Int Cong Virol, Berlin
Falconar AKI, Young PR (1990) Immunoaffinity purification of native dimer forms of the flavivirus nonstructural glycoprotein, NS1. J Virol Methods 30: 323–332
Falconar AKI, Young PR (1991) Production of dimer-specific and dengue group cross-reactive mouse monoclonal antibodies to the dengue 2 virus nonstructural glycoprotein, NS1. J Gen Virol 72: 961–965
Fawkler WA, Diwan AR, Halstead SB (1973) Human antibody to dengue soluble complement fixing (SCF) antigens. J Immunol 111: 1804–1809
Geysen HM, Mason TL, Rodda SJ (1988) Cognitive features of continuous antigenic determinants. J Mol Recogn 1: 32–41
Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG (1987) Strategies for epitope analysis using peptide synthesis. J Immunol Methods 102: 259–274
Hahn YS, Galler R, Hunkapillar T, Dalrymple JM, Strauss JH, Strauss EG (1988) Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology 162: 167–180
Halstead SB (1989) Antibody, macrophage, dengue virus infection, shock and hemorrhage: a pathogenic cascade. Rev Infect Dis 2: 831–839
Halstead SB (1992) The XXth century dengue pandemic: need for surveillance and research. World Health Stat Q 45: 292–298
Henchal EA, Henchal LS, Schlesinger JJ (1988) Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol 69: 2101–2107
Irie K, Mohan PM, Sasaguri Y, Putnak R, Padmanabhan R (1989) Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene 74: 197–211
Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40: 444–451
Kuno J, Vorndam AV, Gubler DJ, Gomez I (1990) Study of anti-dengue NS1 antibody by western blot. J Med Virol 32: 10–108
Laver WG, Air GM, Webster RG, Smith-Gill SJ (1990) Epitopes on protein antigens: misconceptions and realities. Cell 61: 553–556
Leblois H, Young PR (1993) Sequence of the dengue virus type 2 (strain PR 159) NS1 gene and comparison with its vaccine derivative. Nucleic Acids Res 21: 1668
Mackow E, Makino Y, Zhao B, Zhang YM, Markoff L, Buckler-White A, Guiler M, Chanock R, Lai CJ (1987) The nucleotide sequence of dengue type 4 virus: Analysis of genes coding for the nonstructural proteins. Virology 159: 217–228
Mason PW (1989) Maturation of Japanese encephalitis virus glycoproteins in infected mammalian and mosquito cells. Virology 169: 354–364
Mason PW, Dalrymple JM, Gentry MK, Mccown JM, Hoke CM, Burke DS, Fournier MJ, Mason TL (1990) Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70: 2037–2049
Mason PW, McAda PC, Mason TL, Fournier MJ (1987) Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major non-structural protein NS1. Virology 161: 262–267
Mason PW, Zugel MU, Semproni AR, Fournier MJ, Mason TL (1990) The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed inEscherichia coli. J Gen Virol 71: 2107–2242
Megret F, Hugnot JP, Falconar A, Gentry MK, Morens DM, Murray JM, Schlesinger JJ, Wright PJ, Young P, Van Regenmortel MHV, Deubel V (1992) Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187: 480–491
Morens DM, Halstead SB, Marchette NJ (1987) Profiles of antibody dependent enhancement of dengue virus type 2 infection. Microb Pathogen 3: 231–237
Osatomi K, Sumiyoshi H (1990) Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176: 643–647
Prior MJ, Wright PJ (1993) The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194: 769–780
Rico-Hesse R (1990) Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174: 479–493
Schlesinger JJ, Brandriss MW, Walsh EE (1985) Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp 48 and by active immunization with gp 48. J Immunol 135: 2805–2809
Schlesinger JJ, Brandriss MW, Walsh EE (1987) Protection of mice against dengue-2 virus encephalitis by immunization with dengue-2 virus nonstructural glycoprotein NS1. J Gen Virol 68: 853–857
Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192: 132–141
Shiu SYW, Ip KWP, Gould EA, Chan KM (1993) Comparative analysis of the NS1 gene sequences of dengue-1 viruses prototype Hawaii strain and Thai isolate TH-Sman, and determination of the intratypic variation of NS1 protein among dengue-1 viruses. Arch Virol 131: 447–454
Van Regenmortel MHV (1992) The conformational specificities of viral epitopes. FEMS Microbiol Lett 79: 483–487.
Winkler G, Randolph VB, Cleaves GR, Ryan TE, Stollar V (1986) Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162: 187–196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Falconar, A.K.I., Young, P.R. & Miles, M.A. Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Archives of Virology 137, 315–326 (1994). https://doi.org/10.1007/BF01309478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309478